Yong-de Liao-Yongde

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

USP20-mediated PGAM1 stabilization promotes glycolysis and confers osimertinib resistance in non-small cell lung carcinoma.

USP20-mediated PGAM1 stabilization promotes glycolysis and confers osimertinib resistance in non-small cell lung carcinoma.

Journal: Oncogene

Published: November 05, 2025

Prediction of tumor-infiltrating lymphocytes through habitat radiomics and exploration of response mechanisms in neoadjuvant immunochemotherapy-treated lung cancer.

Prediction of tumor-infiltrating lymphocytes through habitat radiomics and exploration of response mechanisms in neoadjuvant immunochemotherapy-treated lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: September 15, 2025

Targeted degradation of estrogen receptor β to overcome Osimertinib resistance in non-small cell lung carcinoma.

Targeted degradation of estrogen receptor β to overcome Osimertinib resistance in non-small cell lung carcinoma.

Journal: Bioorganic chemistry

Published: August 04, 2025

Elevated ERβ expression driven by low ASB8-mediated ubiquitination in lung adenocarcinoma promotes lymph node metastasis via tumor-associated neutrophils.

Elevated ERβ expression driven by low ASB8-mediated ubiquitination in lung adenocarcinoma promotes lymph node metastasis via tumor-associated neutrophils.

Journal: Cell death & disease

Published: February 03, 2025

Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study.

Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study.

Journal: Journal for immunotherapy of cancer

Published: August 04, 2024

CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study.

CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study.

Journal: BMC medical imaging

Published: July 13, 2024

Efficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinoma.

Efficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinoma.

Journal: International immunopharmacology

Published: May 29, 2024

Conversion Surgery for Initially Unresectable Stage Ⅲ Nonsmall Cell Lung Cancer After Induction Treatment of Immunochemotherapy: A Multicenter Study.

Conversion Surgery for Initially Unresectable Stage Ⅲ Nonsmall Cell Lung Cancer After Induction Treatment of Immunochemotherapy: A Multicenter Study.

Journal: Clinical lung cancer

Published: February 03, 2024

A 3D boundary-guided hybrid network with convolutions and Transformers for lung tumor segmentation in CT images.

A 3D boundary-guided hybrid network with convolutions and Transformers for lung tumor segmentation in CT images.

Journal: Computers in biology and medicine

Published: January 28, 2024

METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis.

METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis.

Journal: Cell & bioscience

Published: October 28, 2023

Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer.

Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer.

Journal: Cancer cell international

Published: September 16, 2023

USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma.

USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma.

Journal: Cancer letters

Published: September 15, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026